1406 — Clarity Medical Holding Income Statement
0.000.00%
Last trade - 00:00
- HK$261.42m
- HK$137.20m
- HK$213.85m
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 207 | 218 | 222 | 225 | 214 |
Cost of Revenue | |||||
Gross Profit | 170 | 179 | 185 | 187 | 176 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 166 | 184 | 178 | 205 | 215 |
Operating Profit | 40.7 | 34.3 | 44.7 | 19.8 | -1.39 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 39.5 | 33.2 | 43.8 | 19 | -2.92 |
Provision for Income Taxes | |||||
Net Income After Taxes | 30 | 26.4 | 35.8 | 13.5 | -3.19 |
Net Income Before Extraordinary Items | |||||
Net Income | 30 | 26.4 | 35.8 | 13.5 | -3.19 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 30 | 26.4 | 35.8 | 13.5 | -3.19 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.085 | 0.06 | 0.074 | 0.063 | -0.009 |